{"title":"利妥昔单抗治疗与跟腱病相关吗?","authors":"Mallak Zatreh","doi":"10.26502/josm.511500056","DOIUrl":null,"url":null,"abstract":"Rituximab is a chimeric anti-CD20 monoclonal antibody that is used to treat CD20+ non-Hodgkin's lymphoma, and a wide variety of autoimmune diseases. Rituximab-associated tendinopathy has been described in a few cases in the literature. Here, we present a case of Achilles partial tendon rupture with classic clinical and radiographic findings in a patient treated with rituximab.","PeriodicalId":73881,"journal":{"name":"Journal of orthopaedics and sports medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Is Rituximab Therapy Associated with Achilles Tendinopathy?\",\"authors\":\"Mallak Zatreh\",\"doi\":\"10.26502/josm.511500056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Rituximab is a chimeric anti-CD20 monoclonal antibody that is used to treat CD20+ non-Hodgkin's lymphoma, and a wide variety of autoimmune diseases. Rituximab-associated tendinopathy has been described in a few cases in the literature. Here, we present a case of Achilles partial tendon rupture with classic clinical and radiographic findings in a patient treated with rituximab.\",\"PeriodicalId\":73881,\"journal\":{\"name\":\"Journal of orthopaedics and sports medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of orthopaedics and sports medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26502/josm.511500056\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of orthopaedics and sports medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/josm.511500056","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Is Rituximab Therapy Associated with Achilles Tendinopathy?
Rituximab is a chimeric anti-CD20 monoclonal antibody that is used to treat CD20+ non-Hodgkin's lymphoma, and a wide variety of autoimmune diseases. Rituximab-associated tendinopathy has been described in a few cases in the literature. Here, we present a case of Achilles partial tendon rupture with classic clinical and radiographic findings in a patient treated with rituximab.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
